Critical Care · ECMO · AI in Medicine · Doha, Qatar

Dr. Ali Ait Hssain

MD · PhD · DES-AR (FR) · Senior Consultant Intensivist

ECMO specialist and clinical scientist at Hamad Medical Corporation, Qatar — conducting landmark multicenter research in sepsis, critical care, and AI-driven diagnostics across 26+ countries.

Dr. Ali Ait Hssain
Dr. Ali Ait Hssain
MD · PhD · Senior Consultant Intensivist & ECMO Specialist
📍 Hamad Medical Corporation · Doha, Qatar

About

Clinician.
Scientist. Innovator.

With over two decades of practice across France, Saudi Arabia, and Qatar, I lead critical care and ECMO research at one of the world's most internationally accredited tertiary centers. My PhD from Paris Cité University (2025) focused on the epidemiology of acquired infections in ECMO patients.

My work spans multicenter clinical trials, immunological research in sepsis, AI-assisted diagnostics, and ECMO simulation — with publications in The Lancet, NEJM, JAMA, and Intensive Care Medicine.

Qatar's patient population — 180+ nationalities — makes my institution an unparalleled site for globally diverse research. I actively seek collaborations with leading centers, AI companies, and innovative research networks worldwide.

🏥
Senior Consultant Intensivist & ECMO Consultant
Medical ICU · Hamad General Hospital · Doha, Qatar
December 2014 – Present
🎓
Adjunct Associate Professor
Hamad Bin Khalifa University · Health & Life Sciences
September 2022 – Present
🔬
Clinical Assistant Professor
Weill Cornell Medicine – Qatar
August 2020 – Present
🌐
Elected Middle East Representative
ESICM · European Society of Intensive Care Medicine
October 2023 – Present

Areas of Expertise

Where Science Meets Critical Care

Six core domains shaping my research and clinical practice.

🫀
ECMO
VV and VA-ECMO for ARDS, cardiac arrest, and complex respiratory failure. Expert in cannulation, simulation training, and multicenter outcomes research.
VV-ECMOVA-ECMOECPRSimulation
🧫
Sepsis & Infections
Immunological pathways in sepsis and COVID-19, nosocomial infections in ECMO patients, antimicrobial stewardship, and sepsis phenotyping.
Septic ShockImmunologyNosocomialAMS
🤖
AI & Digital Health
Clinical validation of AI models for early sepsis prediction, ICU deterioration, lung pathology diagnosis, and biosensor development.
ML in ICUBiosensorsPredictionDiagnostics
🫁
ARDS & Ventilation
Mechanical ventilation strategies, prone positioning, respiratory ECMO for TB-related ARDS, and flow-controlled ventilation.
ARDSProningVentilationCOVID-19
🧬
Clinical Epidemiology
PhD-level expertise. Lead investigator in large international multicenter cohort studies and registries across 26+ countries.
MulticenterELSO RegistryISARIC
🏥
Clinical Nutrition
ICU nutrition, body composition, muscle mass assessment — with landmark contributions to NUTRIREA-2 and multiple international trials.
ICU NutritionBody CompositionMetabolism

Selected Publications

Recent Research

Landmark contributions to critical care, ECMO, and sepsis science.

2026
Lancet Respiratory Medicine
Acute respiratory failure in immunocompromised ICU patients — 103 units, 26 countries
Azoulay E, McEvoy C, Ait Hssain A et al. — EFRAIM III
2026
Intensive Care Medicine
Consensus on prevention of peripheral ECMO cannula-site infection — SAVECMO Delphi
Masi P, Abrams D, Ait Hssain A et al. — EuroELSO
2026
BMC Infectious Diseases
Nosocomial infections in ECMO patients in Qatar: CLEAN-Q 7-year retrospective cohort
Ait Hssain A, Bahramnezhad F, Vahedian-Azimi A et al.
2025
Talanta
SERS on blood for rapid, culture-free sepsis recognition using super operational neural networks
Hassan M … Ait Hssain A et al.
2024
Critical Care
ECMO for tuberculosis-related ARDS — international multicentre retrospective cohort
Ait Hssain A, Petit M, Wiest C et al. — TB ECMO Study Group
2024
Critical Care
Incidence, risk factors and outcomes of nosocomial infection in ECMO: systematic review & meta-analysis
Ait Hssain A, Vahedian-Azimi A, Ibrahim AS et al.
Roles & Leadership

Global Society Engagement

Active leadership in the world's leading critical care and ECMO organizations.

ELSO
Chair, Research Subcommittee SWAAC ELSO
May 2026 – Present
ESICM
Elected Middle East Representative
Oct 2023 – Present
ELSO
Guidelines Committee Member
Sept 2024 – Present
ELSO
Education Committee Member
2017 – Present
ELSO Journal
Editorial Board Member, ECLS Journal
2017 – Present
Hamad Medical
Lead, Medical ICU Research Team
Sept 2015 – Present
ECSiTeD
Director, ECMO Simulation Team Doha
Nov 2016 – 2024
Hamad Medical
IRB Member & Deputy Chair
2017 – 2022
Innovation & AI

AI-Driven Critical Care: A Research Frontier

Actively seeking AI and digital health partnerships to advance sepsis detection, ECMO outcomes, and ICU decision support.

🔍
Early Sepsis Prediction
ML models for 6–12h early warning systems in multiethnic ICU populations.
🧬
Sepsis Phenotyping
Endotype classification with deep learning — hyper vs hypo-inflammatory subtypes.
🫀
ECMO Patient Selection
AI-driven outcome prediction and weaning decision support algorithms.
⚗️
Biosensor & Rapid Diagnostics
Culture-free pathogen identification using SERS and neural network models.
🫁
Lung Pathology AI
Systematic survey and clinical validation of AI lung diagnostic tools in ICU.
Partner with Me on AI Research
AI Research Engagement Areas
Sepsis Detection Active
ECMO Outcomes AI Active
Biosensor Diagnostics Published
Lung Pathology AI Published
ICU Decision Support Seeking Partners
💡 Unique value: A multiethnic Gulf ICU cohort (180+ nationalities) for AI model training and validation — an underrepresented dataset globally.


Networks & Affiliations

Scientific Communities

Leadership and active roles in the world's foremost critical care organizations.

SWAAC ELSO
Chair, Research Subcommittee
ECSiTeD · ECMO Simulation Team of Doha
Founder & Ex-Director
Critical Care Network — Africa & Middle East
Founder & Director
ELSO
Extracorporeal Life Support Organization
Guidelines & Education Committee
ESICM
European Society of Intensive Care Medicine
Elected Middle East Representative
ISARIC
International Severe Acute Respiratory Consortium
Collaborating Investigator

Collaborate

Let's Build
Science Together

I welcome research collaborations, clinical advisory roles, AI validation partnerships, and consultancy engagements from leading centers and companies worldwide.

Email a_aithssain@hotmail.com
LinkedIn ali-ait-hssain-78752045
ORCID 0000-0002-7764-5793
Open to Global Collaboration
My center offers internationally accredited infrastructure, a diverse multiethnic patient cohort, QNRF funding eligibility, and fast IRB processes — making it an ideal partner for multicenter studies, AI validation, and clinical trials.
Multicenter Studies AI Validation Clinical Trials Consultancy ECMO Research Sepsis Research Advisory Boards KOL Partnerships Chinese Health Centers AI Companies
Send a Collaboration Request